HILEUKIN-2 Trademark

Trademark Overview


On Wednesday, June 12, 2019, a trademark application was filed for HILEUKIN-2 with the United States Patent and Trademark Office. The USPTO has given the HILEUKIN-2 trademark a serial number of 88469472. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 5, 2021. This trademark is owned by Genexine, Inc.. The HILEUKIN-2 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations for treating malignant tumours; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the prevention of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Biological preparations for the treatment of cancer; Cytostatics for pharmaceutical purposes; Reagents for medical use; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for tumor treatment; Tumor suppressing agents; Antibiotics; Antibiotic preparations; Pharmaceutical preparations being pills for inflammation treatment; Cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting digestive organs; Dermatological pharmaceutical products; Blood solvent, ...
hileukin-2

General Information


Serial Number88469472
Word MarkHILEUKIN-2
Filing DateWednesday, June 12, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations for treating malignant tumours; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the prevention of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Biological preparations for the treatment of cancer; Cytostatics for pharmaceutical purposes; Reagents for medical use; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for tumor treatment; Tumor suppressing agents; Antibiotics; Antibiotic preparations; Pharmaceutical preparations being pills for inflammation treatment; Cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting digestive organs; Dermatological pharmaceutical products; Blood solvent, namely, blood plasma; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for treating anemia; Pharmaceutical preparations for treating dwarfism; Pharmaceuticals for the treatment of diabetes; Pharmaceutical preparations for treating short-bowel syndrome; Pharmaceutical preparations for treating cervical tumor

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenexine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeongnamsi, Gyeonggido 13488
KR

Party NameGenexine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeongnamsi, Gyeonggido 13488
KR

Trademark Events


Event DateEvent Description
Monday, April 5, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, September 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 2, 2020EXTENSION 1 GRANTED
Wednesday, September 2, 2020EXTENSION 1 FILED
Wednesday, September 2, 2020TEAS EXTENSION RECEIVED
Tuesday, March 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, November 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, November 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 26, 2019NON-FINAL ACTION E-MAILED
Monday, August 26, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 20, 2019ASSIGNED TO EXAMINER
Monday, June 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 15, 2019NEW APPLICATION ENTERED IN TRAM